TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Lifeline Pharma AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,667
|
1,719
|
3,077 |
Financial expenses |
73
|
46
|
36 |
Earnings before taxes |
-124
|
75
|
-247 |
Total assets |
1,506
|
1,215
|
1,468 |
Current assets |
1,450
|
1,162
|
1,417 |
Current liabilities |
503
|
842
|
1,428 |
Equity capital |
-147
|
-25
|
-137 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
3
![]() |
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
-9.8%
|
-2.1%
|
-9.3% |
Turnover per employee |
573
|
1,026 | |
Profit as a percentage of turnover |
-7.4%
|
4.4%
|
-8.0% |
Return on assets (ROA) |
-3.4%
|
10.0%
|
-14.4% |
Current ratio |
288.3%
|
138.0%
|
99.2% |
Return on equity (ROE) |
84.4%
|
-300%
|
180.3% |
Change turnover |
57
|
-1,196
|
-540 |
Change turnover % |
4%
|
-41%
|
-15% |
Chg. No. of employees | 0 | ||
Chg. No. of employees % | 0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.